
Keywords: ACE-Is; angiotensin-converting enzyme inhibitors; AH; arterial hypertension; ARBs; angiotensin II receptor antagonists; BMI; body mass index; BP; blood pressure; CA; carbonic anhydrase; cAMP; cyclic adenosine monophosphate; CAT; catalase; CRP; C-reactive